13 research outputs found
Effects of Body Mass Index on Task-Related Oxygen Uptake and Dyspnea during Activities of Daily Life in COPD
<div><h3>Background</h3><p>Patients with COPD use a higher proportion of their peak aerobic capacity during the performance of domestic activities of daily life (ADLs) compared to healthy peers, accompanied by a higher degree of task-related symptoms. To date, the influence of body mass index (BMI) on the task-related metabolic demands remains unknown in patients with COPD. Therefore, the aim of our study was to determine the effects of BMI on metabolic load during the performance of 5 consecutive domestic ADLs in patients with COPD.</p> <h3>Methodology</h3><p>Ninety-four COPD patients and 20 healhty peers performed 5 consecutive, self-paced domestic ADLs putting on socks, shoes and vest; folding 8 towels; putting away groceries; washing up 4 dishes, cups and saucers; and sweeping the floor for 4 min. Task-related oxygen uptake and ventilation were assessed using a mobile oxycon, while Borg scores were used to assess task-related dyspnea and fatigue.</p> <h3>Principal Findings</h3><p>1. Relative task-related oxygen uptake after the performance of domestic ADLs was increased in patients with COPD compared to healthy elderly, whereas absolute oxygen uptake is similar between groups; 2. Relative oxygen uptake and oxygen uptake per kilogram fat-free mass were comparable between BMI groups; and 3. Borg symptom scores for dyspnea en fatigue were comparable between BMI groups.</p> <h3>Conclusion</h3><p>Patients with COPD in different BMI groups perform self-paced domestic ADLs at the same relative metabolic load, accompanied by comparable Borg symptom scores for dyspnea and fatigue.</p> </div
Characteristics.
<p>Results are presented as mean (standard deviation). FEV<sub>1</sub> β=β forced expiratory volume in the first second; L β=β litre; FVC β=β forced vital capacity; kg β=β kilogram; kg/m<sup>2</sup> β=β kilogram per squared meters; Charlson CMI β=β Charlson co-morbidity index <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041078#pone.0041078-Charlson1" target="_blank">[19]</a>; Charlson CMI 2β=β Charlson age comorbidity index <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041078#pone.0041078-Charlson2" target="_blank">[20]</a>; 6MWD β=β six-minute walking distance; VO2β=β oxygen uptake; mL β=β millilitre; min β=β minute; BW β=β body weight; FFM β=β fat free mass; VE β=β minute ventilation; MVV β=β maximum voluntary ventilation; HR β=β heart rate; bpm β=β beats per minute. <sup>*</sup>1 kPa β=β7.5 mm Hg; <sup>**</sup>1 kilogram β=β2.2046 pounds; <sup>β </sup>pβ€0.05 vs. healthy subjects.</p
Borg symptom scores after performance of domestic ADLs.
<p>a. absolute Borg dyspnea scores. b. relative Borg dyspnea scores (%peak). c. absolute Borg fatigue scores. d. relative Borg fatigue scores (%peak).</p
Task-related oxygen uptake in patients with COPD and healthy controls.
<p>a. Absolute task-related oxygen uptake (mL/min). b. Relative task-related oxygen uptake (%peakVO<sub>2</sub>).</p
Baseline characteristics by BMI categories.
<p>Results are presented as mean (standard deviation). FEV<sub>1</sub> β=β forced expiratory volume in the first second; L β=β litre; FVC β=β forced vital capacity; kg β=β kilogram; kg/m<sup>2</sup> β=β kilogram per squared meters; Charlson CMI β=β Charlson co-morbidity index <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041078#pone.0041078-Charlson1" target="_blank">[19]</a>; Charlson CMI 2β=β Charlson age comorbidity index <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041078#pone.0041078-Charlson2" target="_blank">[20]</a>; 6MWD β=β six-minute walking distance; VO2β=β oxygen uptake; mL β=β millilitre; min β=β minute; BW β=β body weight; FFM β=β fat free mass; VE β=β minute ventilation; MVV β=β maximum voluntary ventilation; HR β=β heart rate; bpm β=β beats per minute. <sup>*</sup>1 kPa β=β7.5 mm Hg; <sup>**</sup>1 kilogram β=β2.2046 pounds; <sup>β </sup>p<0.05 vs. <21 kg/m<sup>2</sup> +p<0.05 vs. 21β25 kg/m<sup>2</sup><sup>#</sup>p<0.05 vs. 25β30 kg/m<sup>2</sup>.</p
Task-related oxygen uptake in patients with COPD.
<p>a. Relative task-related oxygen uptake (%peakVO<sub>2</sub>). b. Task-related oxygen uptake per kilogram FFM (mL/min/kg FFM).</p
Task-related ventilation in patients with COPD.
<p>a. Relative task-related ventilation (%peakVE).</p
A and B. Prevalence of metabolic syndrome and its components in male and female COPD and healthy subjects with BMI <25 kg/m<sup>2</sup>.
<p>WC, waist circumference; HDL, high density lipoprotein; Syst BP, systolic blood pressure; Dia BP, diastolic blood pressure; Met Syn, metabolic syndrome.</p
Baseline characteristics of the total study population.
<p>Data are presented: mean Β± SD, percentages or <sup>#</sup>median (interquartile range) if data were not normal distributed.</p><p>FEV<sub>1</sub>, forced expiratory volume in the first second; FVC, forced vital capacity; BMI, body mass index; FFMI, fat free mass index; HDL, high density lipoprotein.</p>$<p>according to the IDF.</p><p>Other symbols:</p><p>*p<0.01,</p>β <p>p<0.05 compared with COPD patients.</p
Clinical and functional characteristics of the COPD patients by metabolic syndrome.
<p>Data are mean Β± SD or percentages or <sup>#</sup>median (interquartile range) if data were not normal distributed.</p><p>FEV<sub>1</sub>, forced expiratory volume in the first second; FVC, forced vital capacity; BMI, body mass index; FFMI, fat free mass index; BMD, bone mineral density; 6MWD, six minute walking distance; LTOT, long term oxygen therapy; PaCO<sub>2</sub>, arterial carbon dioxide tension; PaO<sub>2</sub>, arterial oxygen tension; CVD, cardiovascular disease; inhaled and oral CS, inhaled and oral corticosteroids; MRC, modified Medical Research Council; HADS, Hospital Anxiety and Depression Scale; SGRQ, St. George Respiratory Questionnaire.</p><p>*<i>p</i><0.01,</p>β <p><i>p</i><0.05 compared to patients without the metabolic syndrome.</p